These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10756792)

  • 1. Oral lyophilizate--an alternative for products with low-soluble drugs.
    Gafiţeanu E; Drăgănoiu S; Cojocaru I
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):170-3. PubMed ID: 10756792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Formulations and bioavailability of propyphenazone in lyophilized tablets].
    Gafiţanu E; Dumistrăcel I; Antochi S
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(1-2):127-8. PubMed ID: 1823403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.
    Gohel M; Patel M; Amin A; Agrawal R; Dave R; Bariya N
    AAPS PharmSciTech; 2004 Apr; 5(3):e36. PubMed ID: 15760070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved compression properties of propyphenazone spherical crystals.
    Di Martino P; Di Cristofaro R; Barthélémy C; Joiris E; Palmieri Filippo G; Sante M
    Int J Pharm; 2000 Mar; 197(1-2):95-106. PubMed ID: 10704797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
    Ivic B; Ibric S; Betz G; Zorica D
    Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Propyphenazone. Pharmacology and use].
    Göres E; Kossowicz J; Schneider HG
    Med Monatsschr Pharm; 2004 Mar; 27(3):72-6. PubMed ID: 15032249
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Formulation of an oral solid dosage form containing human interferon-alpha].
    Kristo K; Bajdik J; Márki A; Eros I; Falkay G; Hödi K
    Acta Pharm Hung; 2008; 78(1):31-5. PubMed ID: 18476366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of surfactants of Rofam type on properties of piroxicam tablets.
    Szulc-Musioł B; Jankowski A
    Acta Pol Pharm; 2009; 66(2):195-200. PubMed ID: 19719055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutical studies of oral formulations containing propyphenazone.
    Shekerdjiiski R; Paskov V; Lambov N; Gencheva P; Rachev D; Titeva S; Minkov E
    Pharmazie; 1987 Mar; 42(3):184-6. PubMed ID: 3602076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of an aqueous injection of flurbiprofen.
    Gupta GD; Jain S; Jain NK
    Pharmazie; 1997 Sep; 52(9):709-12. PubMed ID: 9347572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.